Merit Medical Systems reported second-quarter 2026 revenue of $418.8 million, a 10% increase over the prior year, and raised its full-year guidance. Constant currency revenue grew 9%, while organic constant currency revenue also rose 9%, excluding the impact of a strategic divestiture. Non-GAAP earnings per share reached $1.19, up 18% year-over-year, and non-GAAP operating margin expanded to 22.6% from 21.2%. The company now expects full-year 2026 revenue between $1.631 billion and $1.643 billion and non-GAAP earnings per share between $4.25 and $4.35, up from prior guidance of $4.01 to $4.15.
Merit Medical Systems IncMerit Medical beat Q2 revenue and earnings estimates and raised full-year guidance.